Preferred Label : Tinzaparin;
MeSH definition : A low-molecular-weight heparin with anticoagulant properties that is used in the prevention
and treatment of VENOUS THROMBOEMBOLISM, and to prevent clotting during EXTRACORPOREAL
CIRCULATION.;
MeSH hyponym : 2 Propenoic acid, 3 phenyl; 3-phenyl- 2-Propenoic acid;
MeSH Related Number : 3S182ET3UA;
UNII : 7UQ7X4Y489;
Origin ID : D000078222;
UMLS CUI : C0216278;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A low-molecular-weight heparin with anticoagulant properties that is used in the prevention
and treatment of VENOUS THROMBOEMBOLISM, and to prevent clotting during EXTRACORPOREAL
CIRCULATION.
https://www.has-sante.fr/jcms/p_3396881/fr/innohep-tinzaparine-sodique-heparine-de-bas-poids-moleculaire
2022
false
false
false
France
evaluation of the transparency committee
Tinzaparin
tinzaparin sodium
---
https://www.has-sante.fr/portail/jcms/c_2899631/fr/innohep
2019
false
false
false
France
evaluation of the transparency committee
innohep
heparin, low-molecular-weight
Tinzaparin
---
https://www.has-sante.fr/portail/jcms/c_2967181/fr/innohep
2019
false
false
false
France
evaluation of the transparency committee
innohep
Tinzaparin
---
http://www.has-sante.fr/portail/jcms/c_1765200/fr/innohep
2014
false
France
French
venous thromboembolism
neoplasms
tinzaparin sodium
guidelines for drug use
secondary prevention
tinzaparin
insurance, health, reimbursement
venous thromboembolism
heparin, low-molecular-weight
fibrinolytic agents
injections, subcutaneous
heparin, low-molecular-weight
evaluation of the transparency committee
Tinzaparin
---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Tinzaparin.aspx
2010
false
Canada
French
English
heparin, low-molecular-weight
child
heparin, low-molecular-weight
tinzaparin
injections, subcutaneous
fibrinolytic agents
fibrinolytic agents
heparin, low-molecular-weight
drug information
patient education handout
Tinzaparin
Tinzaparin
---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14076a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14610a-fra.php
2010
Canada
English
French
Contraindications, Procedure
mortality
heparin, low-molecular-weight
heparin, low-molecular-weight
aged
fibrinolytic agents
fibrinolytic agents
tinzaparin
venous thromboembolism
acute disease
renal insufficiency
heparin, low-molecular-weight
patient education handout
pharmacovigilance note
Contraindications, Drug
Tinzaparin
Tinzaparin
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-01/innohep_-_ct-6965.pdf
http://www.has-sante.fr/portail/jcms/c_912570/innohep
2009
France
French
tinzaparin
insurance, health, reimbursement
venous thromboembolism
venous thrombosis
pulmonary embolism
heparin, low-molecular-weight
fibrinolytic agents
injections, subcutaneous
heparin, low-molecular-weight
evaluation of the transparency committee
Tinzaparin
---